UK to ‘guarantee’ seven-day access to GPs
September 30, 2014Medical Communications, Research and Development, Sales and Marketing BMA, Cameron, GPs, NHS, UK, doctors
Under a UK Conservative government everyone would have access to GP care seven days a week as well as a …
Gilead to shift plant and expand US manufacturing
September 30, 2014Manufacturing and Production AmBisome, Cayston, Gilead, San Dimas, Viread, california, manufacturing
Gilead Sciences will move its US manufacturing plant about 15 minutes down the road to a 23-acre site in the …
New director for NHS England
September 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, richard jeavons
Richard Jeavons will be joining NHS England as its new director of specialised commissioning. Jeavons will report to Dame Barbara …
Lucideon expands pharma testing facilities
September 29, 2014Manufacturing and Production, Sales and Marketing bioburden, ceram, freeman, labs, lucideon, manufacturing, stoke
Materials development firm Lucideon has opened new pharmaceutical quality control testing laboratories at its UK headquarters in Stoke-on-Trent. The £1.5 …
BMS therapeutic cancer vaccine given swift FDA appraisal
September 29, 2014Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, Vaccine, bristol myers-squibb, keytruda, melanoma, opdivo
Bristol-Myers Squibb has been granted a speedy review for its new cancer immunotherapy drug Opdivo by the FDA for patients …
Boehringer’s lung cancer drug gets EMA nod
September 29, 2014Sales and Marketing Boehringer, IPF, docetaxel, ingelheim, lung cancer, nintedanib
The EMA has issued a positive opinion for the approval of Boehringer Ingelheim’s nintedanib in combination with docetaxel for the …
NHS stem cell research link up
September 29, 2014Research and Development, Sales and Marketing NHS, precious cells group, precious cells miracle, stem cell
Precious Cells Miracle, the charitable arm of stem cell firm Precious Cells Group, has partnered with the Croydon Health Services …
Sovaldi combo sees CHMP green light
September 29, 2014Sales and Marketing CHMP, EU, Gilead, HCV, harvoni, hep C, sovaldi
The CHMP is recommending that Gilead’s new combination hepatitis C drug therapy Harvoni should be approved for use across the …
Roche’s Perjeta sees ‘impressive’ survival rates
September 29, 2014Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid
Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …
Daiichi Sankyo pays $410m for Ambit Biosciences
September 29, 2014Sales and Marketing AML, Daiichi Sankyo, ambit biosciences, quizartinib
Daiichi Sankyo has bought San Diego-based Ambit Biosciences in a deal aimed at shoring up the Japanese company’s cancer research. …
Adaptimmune board changes amid funding boost
September 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Ali Behbahani, Elliott Sigal, Peter Thompson, david mott
Oxford-based biotech firm Adaptimmune has secured some significant financial support whilst also making changes to its board. David Mott (pictured), …
Is clinical research management evidence-based?
September 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Six Sigma, clinical trials, evidence, neuro-linguistic
Those who follow my columns will know that I am in the habit of starting with reminiscences. It’s something that …
Novartis: digital pharma company of the year
September 26, 2014Medical Communications, Sales and Marketing London, McCann Manchester and Red Door Communications, Novartis, pm society
Novartis pipped Bayer and its big pharma rivals Boehringer, Genentech, GSK and Sanofi to the post in receiving the first …
Virgo Health appoints US office head
September 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, nancy caravetta
UK-based healthcare comms agency Virgo Health has launched a PR office in New York and appointed Nancy Caravetta to head …
Shire accused of dishonest marketing in US
September 25, 2014Medical Communications, Sales and Marketing Adderall XR, Department of Justice, DoJ, Shire, US, amphetamine, dextroamphetamine
Shire will pay a fine of $56.5 million to resolve a string of legal allegations in the US surrounding the …
PAN hires two account handlers
September 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Margaux Chung, Pan, Rosemary Behan
Creative agency PAN has appointed two new account handlers in Rosemary Behan (pictured) who joins as account director, and Margaux …
New chairman to take seat at GSK
September 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, RBS, gent, philip hampton
The Royal Bank of Scotland’s chairman Sir Philip Hampton has been appointed by GlaxoSmithKline to succeed Sir Christopher Gent in …
MedImmune and CRUK team up on cancer
September 25, 2014Sales and Marketing AstraZeneca, CRT, CRUK, Cambridge, Cancer, MedImmune
AstraZeneca’s biologics arm MedImmune has joined forces with Cancer Research UK to establish a new research laboratory in Cambridge, UK. …
Avillion hires chief business officer
September 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion, Jarrod Longcor, melinta, rib-x
London-based drug development firm Avillion has confirmed the appointment of Jarrod Longcor as its chief business officer. Longcor joins as …
FDA accepts new schizophrenia drug filing
September 24, 2014Sales and Marketing FDA, Lundbeck, Otsuka, brexpiprazole, depression, schizophrenia
The FDA is reviewing Otsuka and Lundbeck’s brexpiprazole for the treatment of schizophrenia and as an adjunctive therapy for the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
